Cited In for PMID: 15581390

Year	Number of Results
2004	1
2006	2
2007	2
2009	4
2010	1
2011	5
2012	3
2013	3
2014	6
2015	6
2016	3
2017	1
2018	1
2020	2
2021	2
2024	0

1

Evidence-based guidelines for the management of Lyme disease.

Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey C, Horowitz R, Phillips S, Meer-Scherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R; ILADS Working Group. Cameron D, et al. Expert Rev Anti Infect Ther. 2004;2(1 Suppl):S1-13. doi: 10.1586/14789072.2.1.s1. Expert Rev Anti Infect Ther. 2004. PMID: 15581390

2

Acute arthritis of the right temporomandibular joint due to Lyme disease: a case report and literature review.

Weise C, Schulz MC, Frank K, Cetindis M, Koos B, Weise H. Weise C, et al. BMC Oral Health. 2021 Aug 16;21(1):400. doi: 10.1186/s12903-021-01744-4. BMC Oral Health. 2021. PMID: 34399746 Free PMC article. Review.

3

Lyme Disease in Humans.

Radolf JD, Strle K, Lemieux JE, Strle F. Radolf JD, et al. Curr Issues Mol Biol. 2021;42:333-384. doi: 10.21775/cimb.042.333. Epub 2020 Dec 11. Curr Issues Mol Biol. 2021. PMID: 33303701 Free PMC article.

4

Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.

Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz HI, Hunfeld KP, Krause A, Ruf B, Dersch R; Consensus group. Rauer S, et al. Ger Med Sci. 2020 Feb 27;18:Doc03. doi: 10.3205/000279. eCollection 2020. Ger Med Sci. 2020. PMID: 32341686 Free PMC article.

5

The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic.

Davidsson M. Davidsson M. Healthcare (Basel). 2018 Feb 13;6(1):16. doi: 10.3390/healthcare6010016. Healthcare (Basel). 2018. PMID: 29438352 Free PMC article.

6

Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada.

Ogden NH, Arsenault J, Hatchette TF, Mechai S, Lindsay LR. Ogden NH, et al. PLoS One. 2017 Feb 9;12(2):e0171731. doi: 10.1371/journal.pone.0171731. eCollection 2017. PLoS One. 2017. PMID: 28182723 Free PMC article.

7

Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review.

Dersch R, Hottenrott T, Schmidt S, Sommer H, Huppertz HI, Rauer S, Meerpohl JJ. Dersch R, et al. BMC Neurol. 2016 Sep 29;16(1):189. doi: 10.1186/s12883-016-0708-y. BMC Neurol. 2016. PMID: 27686962 Free PMC article.

8

Unique expression of chronic Lyme disease and Jarisch-Herxheimer reaction to doxycycline therapy in a young adult.

Haney C, Nahata MC. Haney C, et al. BMJ Case Rep. 2016 Jul 20;2016:bcr2013009433. doi: 10.1136/bcr-2013-009433. BMJ Case Rep. 2016. PMID: 27440843 Free PMC article.

9

Methodological quality of guidelines for management of Lyme neuroborreliosis.

Dersch R, Toews I, Sommer H, Rauer S, Meerpohl JJ. Dersch R, et al. BMC Neurol. 2015 Nov 25;15:242. doi: 10.1186/s12883-015-0501-3. BMC Neurol. 2015. PMID: 26607686 Free PMC article. Review.

10

Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review.

Dersch R, Sommer H, Rauer S, Meerpohl JJ. Dersch R, et al. J Neurol. 2016 Jan;263(1):17-24. doi: 10.1007/s00415-015-7923-0. Epub 2015 Oct 12. J Neurol. 2016. PMID: 26459093 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year